Evaluation of a Package of Interventions to Reduce the Burden of Malaria in the Urban Daaras of Touba, Senegal - Trial NCT06225297
Access comprehensive clinical trial information for NCT06225297 through Pure Global AI's free database. This Phase 4 trial is sponsored by PATH and is currently Not yet recruiting. The study focuses on Malaria. Target enrollment is 4600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
PATH
Timeline & Enrollment
Phase 4
Jan 01, 2024
Feb 01, 2025
Primary Outcome
Difference in cumulative incidence of clinical malaria confirmed by rapid diagnostic test (RDT) between arms,Difference in pre-post change in prevalence of microscopy-confirmed infection between arms,Difference in pre-post change in prevalence of PCR-confirmed infection between arms
Summary
This study aims to evaluate the effectiveness of the use of adapted insecticide-treated
 mosquito nets combined with extended DHA-PQ-based seasonal chemoprevention for all ages and
 behavior change communication in reducing the burden of malaria in relation to standards of
 protection and care among students (taalibés) in the daaras (Koranic schools) of Touba,
 Senegal.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06225297
Non-Device Trial